MA Munegowda

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Transgene expression of a tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity J Xiang, MA Munegowda and Y Deng Cancer Research Unit, Saskatchewan Cancer Agency, Departments of Oncology, University of Saskatchewan,(More)
Recombinant adenoviral vectors (AdVTNF-alpha) expressing alpha tumor necrosis factor (TNF-alpha) under control of cytomegalovirus (CMV) promoter have been used in cancer gene therapy. To reduce its cytotoxicity, we constructed a recombinant AdV(TERT)mTNF-alpha expressing a mutant TNF-alpha (mTNF-alpha) with mutations at D142N and A144R under control of(More)
  • 1